⌕

Edwards Lifesciences (EW) vs Waters (WAT)

Your goal
● Balanced style: every factor counts equally.
#1 FIT · LEADS
59
Edwards Lifesciences Corp
$107.15 · $62B
Strongest balance sheetHighest qualityFastest grower
of the stocks compared here

The front-runner. Leads the balanced score. Its widest win over the field is balance sheet.

#2 FIT
54
Waters Corp.
$460.25 · $45B
Best returns
of the stocks compared here

The challenger. Trails the leader on the balanced score. Its widest win over the field is total return.

EW edges ahead (59/100 vs WAT 54) under a balanced style, mostly on balance sheet. But WAT wins on total return, so the comparison turns on what you weight. Switch your goal above and watch the scores move.

THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal

FactorEWWAT
Overall fit score
weighted for your balanced goal
✓ 59
54
Valuation
Cheaper for what you get
1×
✓ P/E 61 · EV/EBITDA 40.8
P/E trailing
25
✓ P/E 43 · EV/EBITDA 45.7
P/E fiscal 2025
25
P/E bases differ: trailing for EW, fiscal 2025 for WAT.
Growth
Revenue & earnings momentum
1×
✓ —
55
—
49
Profitability & quality
Margins & return on capital
1×
✓ Net 15% · ROIC 9%
TTM through Sep 30, 2026
73
Net 2% · ROIC 1%
TTM through Oct 3, 2026
57
Total return
Share-price change with dividends reinvested
1×
5Y −1%/yr
51
✓ 5Y +6%/yr
66
Risk (calm = better)
Volatility & drawdown
1×
✓ β 0.6 · DD −54%
84
β 0.9 · DD −36%
81
Balance sheet†
Debt vs cash cushion
1×
✓ Net debt/EBITDA −2.6×
fiscal 2025
73
Net debt/EBITDA 0.8×
fiscal 2025
44
Dividend & income
Cash paid to you
1×
✓ No dividend
39
✓ No dividend
39
Analyst sentiment
Forward EPS growth (consensus)
1×
✓ Est EPS +13%/yr · 17 analysts
69
✓ Est EPS +13%/yr · 12 analysts
69
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
Loading chart…
WHERE EACH ONE IS STRONG
GrowthValueQualityReturnSafetyIncome
■ EW■ WAT
CAN YOU STOMACH THE RIDE?
Worst drawdownBeta (vs market)VolatilityHistory
EW−54%0.5933%5Y
WAT−36%0.8934%5Y
THE CASE FOR & AGAINST EACH
BULL CASE

▲ Leads on balance sheet (score 73). Net debt/EBITDA −2.6× is one of the 5 inputs.

▲ Leads on profitability & quality: Net 15% · ROIC 9% (score 73).

BEAR CASE

▼ Weakest on total return: 5Y −1%/yr (score 51).

BULL CASE

▲ Leads on total return: 5Y +6%/yr (score 66).

BEAR CASE

▼ Weakest on balance sheet (score 44). Net debt/EBITDA 0.8× is one of the 5 inputs.

▼ Weakest on profitability & quality: Net 2% · ROIC 1% (score 57).

WHAT COULD CHANGE THE SCORE
ValuationCurrently 25/100 (P/E 61 · EV/EBITDA 40.8). Taking it to 100 would lift the balanced score by 9 points, the biggest single move available.
Dividend & incomeCurrently 39/100 (No dividend). Taking it to 100 would lift the balanced score by 7 points, the next biggest.
ValuationCurrently 25/100 (P/E 43 · EV/EBITDA 45.7). Taking it to 100 would lift the balanced score by 9 points, the biggest single move available.
Dividend & incomeCurrently 39/100 (No dividend). Taking it to 100 would lift the balanced score by 7 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 16, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.